Drug Shortage Report for YASMIN 21
| Report ID | 169522 |
| Drug Identification Number | 02261723 |
| Brand name | YASMIN 21 |
| Common or Proper name | Drospirenone and Ethinyl Estradiol |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHINYL ESTRADIOL DROSPIRENONE |
| Strength(s) | 0.03MG 3MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 21 |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-09-15 |
| Estimated end date | 2022-09-28 |
| Actual end date | 2022-09-22 |
| Shortage status | Resolved |
| Updated date | 2022-09-23 |
| Company comments | Supply delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-09-23 | French | Compare |
| v5 | 2022-09-23 | English | Compare |
| v4 | 2022-09-22 | French | Compare |
| v3 | 2022-09-22 | English | Compare |
| v2 | 2022-09-16 | French | Compare |
| v1 | 2022-09-16 | English | Compare |
Showing 1 to 6 of 6